Endo stock jumps 12% after Qualitest buy
September 28, 2010 at 11:17 AM EDT
Endo shares rally to a three-year high after the company says it will buy a generic drug maker for $1.2 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.